|
Dronedarone in high-risk permanent atrial fibrillation
Connolly, Stuart J., Camm, A. John, Halperin, Jonathan L., Joyner, Campbell, Alings, Marco, Amerena, John, Atar, Dan, Avezum, Alvaro, Blomstroem, Per, Borggrefe, Martin, Budaj, Andrzej, Chen, Shih-Ann, Ching, Chi Keong, Commerford, Patrick, Dans, Antonio, Davy, Jean-Marc, Delacretaz, Etienne, Di Pasquale, Giuseppe, Diaz, Rafael, Dorian, Paul, Flaker, Greg, Golitsyn, Sergey, Gonzalez-Hermosillo, Antonio, Granger, Christopher B., Heidbuechel, Hein, Kautzner, Josef, Kim, June Soo, Lanas, Fernando, Lewis, Basil S., Merino, Jose L., Morillo, Carlos, Murin, Jan, Narasimhan, Calambur, Paolasso, Ernesto, Parkhomenko, Alexander, Peters, Nicholas S., Sim, Kui-Hian, Stiles, Martin K., Tanomsup, Supachai, Toivonen, Lauri, Tomcsanyi, Janos, Torp-Pedersen, Christian, Tse, Hung-Fat, Vardas, Panos, Vinereanu, Dragos, Xavier, Denis, Zhu, Jun, Zhu, Jun-Ren, Baret-Cormel, Lydie, Weinling, Estelle, Staiger, Christoph, Yusuf, Salim, Chrolavicius, Susan, Afzal, Rizwan, Hohnloser, Stefan H., The PALLAS Investigators and Colquhoun, D. (2011) Dronedarone in high-risk permanent atrial fibrillation. New England Journal of Medicine, 365 24: 2268-2276. doi:10.1056/NEJMoa1109867
|
|
Attached Files
(Some files may be inaccessible until you login with your UQ eSpace credentials)
|
Name |
Description |
MIMEType |
Size |
Downloads |
UQ382409_OA.pdf
|
|
Full text (open access)
|
|
application/pdf
|
465.83KB
|
0
|
|
|
|